Aberrant expression of AK5 is closely linked to metabolic imbalance, neuroprotection, and tumor progression [75], suggesting its potential as a biomarker or therapeutic target for energy metabolism-related diseases [23]. The gene discussed is AK5; the disease is neoplasm.